What Fueled Urinary Tract Infection Testing Devices Market?
The urinary tract infection testing devices market has seen considerable growth due to a variety of factors.
• In recent years, the market size of devices used for urinary tract infection testing has significantly expanded. Predictions show an increase from $0.62 billion in 2024 to $0.67 billion by 2025, marking a compound annual growth rate (CAGR) of 6.9%.
Factors contributing to this historic growth include the rising burden of disease, an upward trend in urinary tract infections worldwide, a high occurrence of diabetes in low and middle-income countries, an increase in hospital-acquired urinary tract infections, and a growing prevalence of antibiotic-resistant urinary tract infection.
What Can Be Expected from the Urinary Tract Infection Testing Devices Market in the Coming Years?
The urinary tract infection testing devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for urinary tract infection testing devices is anticipated to witness robust growth in the near future. Its size is projected to reach $0.86 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%.
The growth during the forecast period is likely due to rising popularity of self-testing and at-home kits, a growing inclination for early disease detection, and an increasing sense of urgency to tackle antibiotic resistance. Key trends forecasted for this period include integration of artificial intelligence and machine learning, developments in at-home testing, technological progression, diagnostics based on nanotechnology, and diagnostic tools based on CRISPR.
What Are The Essential Drivers Behind The Growth Of The Urinary Tract Infection Testing Devices Market?
The escalation in instances of urinary tract infections (UTIs) is anticipated to drive the expansion of the urinary tract infection testing devices market. UTIs are infections which impact any part of the urinary system such as kidneys, ureters, bladder, or urethra, and are generally bacterial, with Escherichia coli being the prominent pathogen. The rise in UTIs can be attributed to factors like ongoing use of catheters, poor hygiene practices, and a surge in antimicrobial resistance among hospital patients. Testing devices for UTIs offer patients a quick and precise diagnosis, enabling medical practitioners to detect the precise pathogens and promptly initiate the appropriate treatments. This can result in fewer complications, enhanced patient outcomes, and prevention of the spread of antimicrobial resistance in healthcare environments. For instance, in March 2024, the University of New South Wales, a public research university in Australia, reported that UTIs are widespread infections, with a global incidence surpassing 400 million cases annually. Thus, the increasing prevalence of UTIs is fueling the urinary tract infection testing devices market's growth.
How Are The Segments Defined Within The Global Urinary Tract Infection Testing Devices Market?
The urinary tract infection testing devices market covered in this report is segmented –
1) By Product type: Instruments, Kits
2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing
3) By End-User: Hospitals, Diagnostic Labs, Other End Users
Subsegments:
1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)
2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits
Pre-Book The Urinary Tract Infection Testing Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Urinary Tract Infection Testing Devices Market Landscape?
Leading firms in the urinary tract infection testing devices market are gravitating towards point-of-care (POC) testing devices to enable quicker and more user-friendly diagnoses, driving better patient outcomes. Point-of-care (POC) testing devices are medical diagnostic equipment used at or near the area of patient care, such as in a home, a doctor's office or at a hospital bedside, eliminating the need for sending samples to a lab. For instance, Sysmex Corporation, a Japan-based company specializing in manufacturing urinary tract infection testing devices, introduced PA-100 AST System in June 2023. This is a Point-of-Care Testing System designed to detect antimicrobial susceptibility. It can identify the presence or absence of bacteria and evaluate the efficiency of antimicrobials swiftly. It can report the growth of bacteria in urine samples roughly in 10 minutes, and provide susceptibility test results in less than 30 minutes. Consequently, healthcare professionals can conduct rapid testing right from a patient's urine samples if a UTI is suspected.
Who Are the Key Players in the Urinary Tract Infection Testing Devices Market?
Major companies operating in the urinary tract infection testing devices market are include:
• Cardinal Health Inc.
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Medtronic plc
• Siemens Healthcare GmbH
• Stryker Corporation
• Laboratory Corporation of America Holdings
• Biomerieux Pvt. Ltd.
• Coloplast A/S
• Sysmex Corporation
• Quidel Corporation
• Teleflex Incorporated
• Teleflex Incorporated
• Bio-Rad Laboratories
• QIAGEN NV
• ACON Laboratories Inc.
• Randox Laboratories Ltd.
• ARKRAY Inc.
• T2 Biosystems Inc.
What Is The Most Dominant Region In The Urinary Tract Infection Testing Devices Market?
North America was the largest region in the urinary tract infection testing devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
